AA
PFE icon

AlphaQ Advisors’s Pfizer PFE Stock Holding History

AlphaQ Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8,240
Closed -$238K – 35
2024
Q3 		$238K Buy
+8,240
New +$240K 0.66% 30
2024
Q1 		– Sell
-8,174
Closed -$235K – 165
2023
Q4 		$235K Buy
+8,174
New +$247K 0.16% 137
2023
Q1 		– Sell
-5,892
Closed -$302K – 179
2022
Q4 		$302K Buy
+5,892
New +$282K 0.26% 102

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AlphaQ Advisors's PFE Position: Q4 2024 in Review

AlphaQ Advisors sold out of Pfizer (PFE) in Q4 2024, closing a stake of 8,240 shares — an estimated $238K sold.

AlphaQ Advisors first reported a position in PFE in Q4 2022 and held it in 3 quarters. The position peaked at $302K in Q4 2022. 2,996 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • AlphaQ Advisors reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • AlphaQ Advisors sold 8,240 Pfizer shares in Q4 2024, an estimated $238K.
  • AlphaQ Advisors first reported a position in Pfizer in Q4 2022 and held it in 3 quarters.
  • AlphaQ Advisors's Pfizer position peaked at $302K in Q4 2022.
  • 2,996 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on AlphaQ Advisors's 13F filing for Q4 2024, filed 18 Feb 2025.